Investment Objective - The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.
Name | Assets (%) | Sector | Instrument |
---|---|---|---|
11.31 | Equity | ||
7.57 | Equity | ||
7.37 | Equity | ||
7.17 | Equity | ||
5.37 | Equity | ||
4.01 | Equity | ||
3.82 | Equity | ||
3.76 | Equity | ||
3.54 | Equity | ||
2.82 | Equity |
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y | SI | |
---|---|---|---|---|---|---|---|---|---|
Fund Returns (%) | -2.41 | -2.16 | 4.29 | 6.89 | NA | NA | NA | NA | 21.82 |
Category Average (%) | -1.90 | 0.23 | 1.07 | 9.55 | -2.69 | 9.99 | 9.43 | NA | 14.01 |
Rank within Category | 963 | 873 | 167 | 622 | 73 | NA | NA | NA | 125 |
* Returns over 1 year are CAGR
Scheme Name(Growth Regular) | NAV (Rs) | AUM (Rs Cr) | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) | 10Y(%) | SI(%) | ER(%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
35.86 | 29,718 | -1.38 | 0.25 | 0.28 | 7.85 | -1.02 | 23.43 | 32.20 | NA | 21.01 | 1.58 | |
194.57 | 14,734 | -4.19 | -3.09 | -5.47 | 2.28 | -9.05 | 15.65 | 19.33 | 16.41 | 12.30 | 1.74 | |
24.79 | 13,643 | -1.20 | 0.16 | 1.93 | 11.02 | 2.61 | 23.19 | NA | NA | 21.38 | 1.70 | |
11.06 | 11,537 | -1.96 | 1.64 | 4.97 | 12.91 | -2.53 | NA | NA | NA | 7.71 | 1.74 | |
45.80 | 11,520 | -4.68 | -3.17 | -6.58 | 0.66 | -12.82 | 15.47 | 19.25 | NA | 16.89 | 1.67 | |
10.15 | 10,123 | -0.78 | 1.70 | 0.40 | 8.09 | -1.36 | NA | NA | NA | 1.27 | 1.73 | |
132.65 | 9,688 | -1.01 | -0.58 | -1.70 | 8.36 | 2.10 | 15.55 | 22.32 | 13.86 | 16.32 | 1.81 | |
10.47 | 9,412 | -1.29 | 1.29 | -0.92 | 7.41 | -11.37 | NA | NA | NA | 2.96 | 1.79 | |
42.62 | 8,371 | -0.88 | 0.60 | -0.35 | 9.89 | 7.19 | 18.63 | 23.04 | 16.74 | 14.70 | 1.79 | |
508.13 | 8,357 | -2.99 | -2.75 | -0.58 | 3.90 | -2.67 | 22.77 | 17.96 | 12.68 | 20.24 | 1.80 |
Over the past
Total investment of ₹5000
Would have become ₹5,298 (+5.96%)
Mr. Ramesh Mantri holds MBA, CFA and CA. His prior assignments include White Oak Capital Management LLP, Ashoka Capital Advisers, Smith Management-Mumbai Office and CRISIL.
View MoreHere is the list of funds managed by Ramesh Mantri
Scheme Name(Growth Regular) | Category | NAV(Rs) | AUM(Rs Cr) | 1Y(%) | 5Y(%) |
---|---|---|---|---|---|
Equity - Flexi Cap | 17.30 | 5,744 | -1.09 | NA | |
Equity - Mid Cap | 19.33 | 3,582 | 1.94 | NA | |
Hybrid - Multi Asset Allocation | 14.58 | 3,422 | 12.95 | NA | |
Equity - Multi Cap | 15.10 | 2,262 | 2.02 | NA | |
Hybrid - Dynamic Asset Allocation/Balanced Advantage | 14.34 | 1,812 | 2.91 | NA | |
Equity - Large & Mid Cap | 13.10 | 1,781 | -0.51 | NA | |
Equity - Large Cap | 14.84 | 1,014 | -2.20 | NA | |
Equity - Sectoral/Thematic | 10.44 | 595 | NA | NA | |
Hybrid - Arbitrage | 10.69 | 586 | 6.50 | NA | |
Equity - Sectoral/Thematic | 12.40 | 468 | 4.34 | NA |
Scheme Name(Growth Regular) | NAV (Rs) | AUM (Rs Cr) | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) | 10Y(%) | SI(%) | ER(%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
17.30 | 5,744 | -1.83 | -0.43 | -0.05 | 9.25 | -1.09 | 18.88 | NA | NA | 19.01 | 1.78 | |
19.33 | 3,582 | -1.89 | -0.41 | 1.24 | 13.88 | 1.94 | 24.52 | NA | NA | 24.14 | 1.86 | |
14.58 | 3,422 | -0.03 | 2.14 | 3.54 | 10.23 | 12.95 | NA | NA | NA | 17.43 | 1.60 | |
15.10 | 2,262 | -1.77 | -0.31 | 1.28 | 12.40 | 2.02 | NA | NA | NA | 22.86 | 1.97 | |
14.34 | 1,812 | -1.20 | -0.20 | 0.21 | 6.42 | 2.91 | NA | NA | NA | 14.76 | 2.03 | |
13.10 | 1,781 | -1.67 | -0.37 | 0.26 | 10.37 | -0.51 | NA | NA | NA | 16.67 | 2.04 |